These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11203206)

  • 1. Hyperprothrombinemia may result in scquired activated protein C reistance.
    Tripodi A; Chantarangkul V; Mannucci PM
    Blood; 2000 Nov; 96(9):3295-6. PubMed ID: 11203206
    [No Abstract]   [Full Text] [Related]  

  • 2. Double heterozygosity for Factor V Leiden and Factor V Cambridge mutations associated with low levels of activated protein C resistance in a Spanish thrombophilic family.
    Santamaría A; Soria JM; Tirado I; Mateo J; Coll I; Souto JC; Fontcuberta J
    Thromb Haemost; 2005 Jun; 93(6):1193-5. PubMed ID: 15968408
    [No Abstract]   [Full Text] [Related]  

  • 3. Deep vein thrombosis and pulmonary embolism: a single disease entity with different risk factors?
    Perrier A
    Chest; 2000 Nov; 118(5):1234-6. PubMed ID: 11083667
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor V Cambridge mutation and activated protein C resistance assays.
    Le Cam-Duchez V; Chrétien MH; Saugier-Veber P; Borg JY
    Thromb Haemost; 2006 Mar; 95(3):581-3. PubMed ID: 16525593
    [No Abstract]   [Full Text] [Related]  

  • 5. Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction.
    Redondo M; Watzke HH; Stucki B; Sulzer I; Biasiutti FD; Binder BR; Furlan M; Lämmle B; Wuillemin WA
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1020-5. PubMed ID: 10195931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Roche LightCycler: a simple and rapid method for direct detection of factor V Leiden and prothrombin G20210A genotypes from blood samples without the need for DNA extraction.
    Cooper PC; Cooper SM; Smith JM; Kitchen S; Makris M
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):499-503. PubMed ID: 12851538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of factor V Leiden mutation and 20210A prothrombin variant in Hungary.
    Balogh I; Póka R; Pfliegler G; Dékány M; Boda Z; Muszbek L
    Thromb Haemost; 1999 Apr; 81(4):660-1. PubMed ID: 10235459
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiplex PCR for one-step determination of the G20210A variation and the factor V Leiden mutation by denaturing gradient gel electrophoresis (DGGE).
    Patri S; Salmeron S; Caillon M; Kitzis A; Chomel JC
    Thromb Haemost; 1999 Feb; 81(2):313-4. PubMed ID: 10064013
    [No Abstract]   [Full Text] [Related]  

  • 9. High frequency of factor V Leiden mutation and prothrombin 20210A variant in Romanies of Eastern Hungary.
    Balogh I; Póka R; Losonczy G; Muszbek L
    Thromb Haemost; 1999 Nov; 82(5):1555-6. PubMed ID: 10595655
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancer.
    Paspatis GA; Sfyridaki A; Papanikolaou N; Triantafyllou K; Livadiotaki A; Kapsoritakis A; Lydataki N
    Pathophysiol Haemost Thromb; 2002; 32(1):2-7. PubMed ID: 12214157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factors.
    Taralunga C; Gueguen R; Visvikis S; Regnault V; Sass C; Siest G; Lecompte T; Wahl D
    Br J Haematol; 2004 Aug; 126(3):392-7. PubMed ID: 15257712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.
    Mahmood A; Needham J; Prosser J; Mainwaring J; Trebble T; Mahy G; Ramage J
    Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):739-44. PubMed ID: 15947551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic analysis after allograft: prudence!].
    Billon S; Mercier B; Férec C; Abgrall JF
    Presse Med; 2000 Jul 8-15; 29(24):1353. PubMed ID: 10938691
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism.
    Haim N; Lanir N; Hoffman R; Haim A; Tsalik M; Brenner B
    Am J Med; 2001 Feb; 110(2):91-6. PubMed ID: 11165549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activated protein C resistance].
    Matsuo T; Suzuki S; Kobayashi H
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):20-3. PubMed ID: 9851075
    [No Abstract]   [Full Text] [Related]  

  • 17. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
    Reitsma PH; van de Stolpe A
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden.
    Van Cott EM; Khor B; Zehnder JL
    Am J Hematol; 2016 Jan; 91(1):46-9. PubMed ID: 26492443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An even easier method for one-step detection of both FV Leiden and FII G20210A transition.
    Muriel G; Christine B; Philippe J; Christophe M; Francois SJ; Patricia AM
    Blood; 1998 Nov; 92(9):3478-9. PubMed ID: 9787193
    [No Abstract]   [Full Text] [Related]  

  • 20. Demystifying two common genetic predispositions to venous thrombosis.
    Deitcher SR; Caiola E; Jaffer A
    Cleve Clin J Med; 2000 Nov; 67(11):825-6, 829, 833-6. PubMed ID: 11104333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.